The Nation - News from June 12, 1987

A drug tested in Tokyo reduces levels of cholesterol in the blood by up to 30% in patients with high levels of the artery-clogging substance, researchers said. The drug, CS-514, inhibits an enzyme key to the production of cholesterol, said doctors at Tokai University Tokyo Hospital. Side effects “were not serious and were fully acceptable when compared with the benefits,” the researchers said in findings published in the Journal of the American Medical Assn. The drug still must be tested with a large number of patients, the study said.